Reported 5,539 shares, down 690 (11.1%) from the prior quarter.
Reported value -18.2%; share count -11.1% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 9000 |
| 2021-12-31 | 8000 |
| 2022-03-31 | 7000 |
| 2022-06-30 | 0 |
| 2023-12-31 | 25 |
| 2024-03-31 | 11 |
| 2024-06-30 | 16 |
| 2024-09-30 | 24 |
| 2024-12-31 | 7 |
| 2025-03-31 | 7 |
| 2025-06-30 | 4 |
| 2025-09-30 | 3 |
| 2025-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2025 | Reduced | 0 | -3 (-100.0%) | 0 | $0 | 2026-02-13 | |
| Q3 2025 | Unchanged | 3 | 0 (0.0%) | < 0.01% | $3 | 2025-11-14 | |
| Q2 2025 | Reduced | 3 | -3 (-50.0%) | < 0.01% | $4 | 2025-08-15 | |
| Q1 2025 | Unchanged | 6 | 0 (0.0%) | < 0.01% | $7 | 2025-05-15 | |
| Q4 2024 | Reduced | 6 | -2 (-25.0%) | < 0.01% | $7 | 2025-02-14 | |
| Q3 2024 | Added | 8 | +2 (33.3%) | < 0.01% | $24 | 2024-11-14 | |
| Q2 2024 | Unchanged | 6 | 0 (0.0%) | < 0.01% | $16 | 2024-08-14 | |
| Q1 2024 | Reduced | 6 | -2 (-25.0%) | < 0.01% | $11 | 2024-05-15 | |
| Q4 2023 | New | 8 | +8 (0.0%) | < 0.01% | $25 | 2024-02-13 | |
| Q2 2022 | Reduced | 0 | -5,539 (-100.0%) | 0 | $0 | 2022-08-15 | |
| Q1 2022 | Unchanged | 5,539 | 0 (0.0%) | < 0.01% | $7,000 | 2022-05-13 | |
| Q4 2021 | Unchanged | 5,539 | 0 (0.0%) | < 0.01% | $8,000 | 2022-02-14 | |
| Q3 2021 | Reduced | 5,539 | -690 (-11.1%) | < 0.01% | $9,000 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
16 managers reported AKARI THERAPEUTICS PLC SPONSOR for Q3 2021.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Omnia Family Wealth LLC | Unchanged | 467,085 | 0 | 0.52% | $761,000 | 8 qtrs |
| NEA Management Company LLC | Unchanged | 452,167 | 0 | < 0.01% | $737,000 | 25 qtrs |
| Hikari Power Ltd | Unchanged | 89,815 | 0 | 0.01% | $146,000 | 18 qtrs |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 65,350 | -86,046 | < 0.01% | $107,000 | 11 qtrs |
| CITADEL ADVISORS LLC | Reduced | 37,770 | -14,495 | < 0.01% | $62,000 | 3 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Unchanged | 30,264 | 0 | < 0.01% | $49,000 | 3 qtrs |
| HighTower Advisors LLC | Reduced | 20,000 | -6,000 | < 0.01% | $33,000 | 9 qtrs |
| HRT FINANCIAL LP | Reduced | 19,569 | -2,236 | < 0.01% | $31,000 | 6 qtrs |
| MILLENNIUM MANAGEMENT LLC | New | 15,276 | +15,276 | < 0.01% | $25,000 | 1 qtr |
| PNC FINANCIAL SERVICES GROUP INC | Unchanged | 12,000 | 0 | < 0.01% | $20,000 | 6 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2021
- Filed
- November 15, 2021
- Filing type
- 13F-HR
- Position type
- SPONSORED ADR
Voting authority reported
- Sole
- 5,539
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.